Source link : https://www.newshealth.biz/health-news/ixo-vec-gene-therapy-reduces-anti-vegf-injections-in-namd/
STOCKHOLM — Trial results are demonstrating positive findings for a single intravitreal injection gene therapy for patients with neovascular age-related macular degeneration (nAMD) who previously required frequent treatments. Researchers speaking here at the American Society of Retina Specialists (ASRS) 2024 Annual Meeting reported that a single intravitreal injection of ixoberogene soroparvovec (Ixo-vec, Adverum Biotechnologies): significantly […]
Author : News Health
Publish date : 2024-07-18 06:30:59
Copyright for syndicated content belongs to the linked Source.
Categories